Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

A Locally Administered Novel Heparin Complex Attenuates Collagen-Induced Platelet Activation and Thrombosis In Vivo ,

Riitta Lassila, MD, PhD, Associate Professor, Annukka Jouppila, M.Sci, Ulla M Marzec, MS, Stephen R Hanson, PhD, Prof.

Blood (2011) 118 (21): 3361.

https://doi.org/10.1182/blood.V118.21.3361.3361

Published: 2011

Journal Articles

Apple Domain-Specific Anti-Factor XI Antibodies Inhibit Venous-Type Thrombosis with Improved Hemostatic Safety Profiles Compared to Enoxaparin in Primates

Erik I. Tucker, PhD, Ulla M Marzec, MS, Philberta Y Leung, PhD, Stephen R Hanson, PhD, Prof., Norah G Verbout, PhD, Sawan Hurst, MS, Owen J.T. McCarty, PhD, David Gailani, MD, Andras Gruber, MD

Blood (2011) 118 (21): 1173.

https://doi.org/10.1182/blood.V118.21.1173.1173

Published: 2011

Journal Articles

Moderate Pharmacological Platelet Count Reduction Limits Thrombus Formation without Hemostatic Impairment in Primates

Erik I Tucker, Ulla M Marzec, Sawan Hurst, András Gruber, MD, Stephen R Hanson, PhD

Blood (2008) 112 (11): 1033.

https://doi.org/10.1182/blood.V112.11.1033.1033

Published: 2008

Journal Articles

Inhibition of Factor XI Decreases Thrombin Production and Prevents Vascular Occlusion in Experimental Thrombosis in Primates.

Erik I. Tucker, BS, Ulla M. Marzec, MS, Andras Gruber, MD, Stephen R. Hanson, PhD

Blood (2007) 110 (11): 763.

https://doi.org/10.1182/blood.V110.11.763.763

Published: 2007

Journal Articles

Factor XI Deficiency Confers a Survival Advantage in a Murine Sepsis Model.

David Gailani, MD, Erik I. Tucker, BS, Qiufang Cheng, MD, Stephen R. Hanson, PhD, Andras Gruber, MD

Blood (2006) 108 (11): 1005.

https://doi.org/10.1182/blood.V108.11.1005.1005

Published: 2006

Journal Articles

Thrombomodulin-Dependent Protein C Activator Treatment Improves the Short-Term Outcome of Experimental Ischemic Stroke in Mice.

Andras Gruber, MD, Patricia D. Hurn, PhD, Sawan Hurst, BS, Leslie Bush, MS, Ulla M. Marzec, MS, Erik Tucker, BS, Stephen R. Hanson, PhD, Enrico Di Cera, MD

Blood (2006) 108 (11): 895.

https://doi.org/10.1182/blood.V108.11.895.895

Published: 2006

Journal Articles

Antithrombotic Activity of PRT54021, a Potent Oral Direct Factor Xa Inhibitor, Can Be Monitored Using a Novel Prothrombinase Inhibition Bioassay.

Uma Sinha, PhD, Susan T. Edwards, MS, Paul W. Wong, BS, Suzanne M. Delaney, PhD, Nisha Nanda, PhD, Ulla M. Marzec, MS, Yvonne Pak, PhD, Stanley J. Hollenbach, JD, Stephen R. Hanson, PhD

Blood (2006) 108 (11): 907.

https://doi.org/10.1182/blood.V108.11.907.907

Published: 2006

Journal Articles

Safe Interruption of Ongoing Thrombosis by the Protein C Activator Thrombin Analog, W215A/E217A; a Comparison to Enoxaparin in Primates.

Ulla M. Marzec, MS, Leslie Bush, MA, Erik Tucker, BS, Andras Gruber, MD, Stephen R. Hanson, PhD, Enrico Di Cera, MD

Blood (2006) 108 (11): 909.

https://doi.org/10.1182/blood.V108.11.909.909

Published: 2006

Journal Articles

Subcutaneous Dosing of CRA-027483, a Small Molecule FVIIa Inhibitor, Prevents Arterial Thrombosis in a Baboon Model.

Ulla M. Marzec, Juthamas Sukbuntherng, Ph.D, Stacie A. Dalrymple, Ph.D, Wendy B. Young, Ph.D, Dange Vijaykumar, PhD, Peter R. Young, Ph.D, Stephen R. Hanson, PhD

Blood (2005) 106 (11): 1867.

https://doi.org/10.1182/blood.V106.11.1867.1867

Published: 2005

Journal Articles

Comparison of Enoxaparin to the Thrombin Variant Protein C Activator, W215A/E217A, in a Primate Model of Thrombosis.

Ulla M. Marzec, Leslie Bush, MA, Andras Gruber, MD, Stephen R. Hanson, PhD, Enrico Di Cera, MD

Blood (2005) 106 (11): 1868.

https://doi.org/10.1182/blood.V106.11.1868.1868

Published: 2005

Journal Articles

Sustained Pharmacological Activation of Protein C (PC) in Baboons.

Andras Gruber, MD, Jose A. Fernandez, MD, PhD, Ulla M. Marzec, Leslie Bush, John H. Griffin, PhD, Stephen R. Hanson, PhD, Enrico Di Cera, MD

Blood (2004) 104 (11): 3499.

https://doi.org/10.1182/blood.V104.11.3499.3499

Published: 2004

NARROW

A Locally Administered Novel Heparin Complex Attenuates Collagen-Induced Platelet Activation and Thrombosis In Vivo ,

Apple Domain-Specific Anti-Factor XI Antibodies Inhibit Venous-Type Thrombosis with Improved Hemostatic Safety Profiles Compared to Enoxaparin in Primates

Moderate Pharmacological Platelet Count Reduction Limits Thrombus Formation without Hemostatic Impairment in Primates

Inhibition of Factor XI Decreases Thrombin Production and Prevents Vascular Occlusion in Experimental Thrombosis in Primates.

Factor XI Deficiency Confers a Survival Advantage in a Murine Sepsis Model.

Thrombomodulin-Dependent Protein C Activator Treatment Improves the Short-Term Outcome of Experimental Ischemic Stroke in Mice.

Antithrombotic Activity of PRT54021, a Potent Oral Direct Factor Xa Inhibitor, Can Be Monitored Using a Novel Prothrombinase Inhibition Bioassay.

Safe Interruption of Ongoing Thrombosis by the Protein C Activator Thrombin Analog, W215A/E217A; a Comparison to Enoxaparin in Primates.

Subcutaneous Dosing of CRA-027483, a Small Molecule FVIIa Inhibitor, Prevents Arterial Thrombosis in a Baboon Model.

Comparison of Enoxaparin to the Thrombin Variant Protein C Activator, W215A/E217A, in a Primate Model of Thrombosis.

Sustained Pharmacological Activation of Protein C (PC) in Baboons.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only